Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?


OverviewForecastRevenueFinancialsChart

Citius Pharmaceuticals Ownership Summary


Citius Pharmaceuticals is owned by 5.20% institutional investors, 1.80% insiders, and 93.01% retail investors. Vanguard group is the largest institutional shareholder, holding 1.80% of CTXR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.60% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCitius Pharmaceuticals5.20%1.80%93.01%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group199.26K1.80%$154.82K
Geode capital management246.16K1.15%$221.56K
Blackrock1.81M1.14%$1.05M
Vanguard fiduciary trust77.75K0.36%$69.98K
Blackrock funding, inc. /de69.85K0.33%$62.87K
Ubs group55.02K0.26%$49.52K
Northern trust43.97K0.20%$39.58K
Arkadios wealth advisors20.00K0.18%$24.80K
Susquehanna group, llp36.84K0.17%$33.15K
Lpl financial25.05K0.12%$22.54K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Miller financial services14.00K0.01%$12.60K
Chelsea counsel4.63K0.00%$3.60K
Arkadios wealth advisors20.00K0.00%$24.80K
Xtx topco21.30K0.00%$19.17K
Quent capital4.26K0.00%$3.84K
Sbi securities6.52K0.00%$5.87K
Tower research capital llc (trc)2.79K0.00%$2.51K
Ifp advisors7.08K0.00%$6.38K
Smallwood wealth investment management120.000.00%$108.00
Wr wealth planners---

Top Buyers

HolderShares% AssetsChange
Geode capital management246.16K-118.63K
Bank of america corp /de/159.42K-107.23K
Vanguard fiduciary trust77.75K-77.75K
Vanguard group199.26K-32.87K
Citadel advisors24.70K-24.70K

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.28M
Blackrock1.81M--6.92M
Millennium management---1.16M
Heights capital management---799.93K
Nuveen asset management---484.65K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust77.75K-77.75K$69.98K
Miller financial services14.00K0.01%14.00K$12.60K
Macquarie group6.89K-6.89K$4.02K
Russell investments group5.46K-5.46K$3.19K
Assetmark372.00-372.00$335.00

Sold Out

HolderChange
Td waterhouse canada-4.00
Northwestern mutual wealth management-8.00
Eversource wealth advisors-16.00
Nelson, van denburg & campbell wealth management group-18.00
Wells fargo & company/mn-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026437.50%1,360,56036.48%526.19%2140.00%912.50%
Mar 31, 202620-51.22%430,949-74.95%23.13%10-47.37%2-60.00%
Dec 31, 202533-10.81%1,689,986170.65%1547.46%16-5.88%3-40.00%
Sep 30, 202535-612,699-34.03%57.82%1713.33%5-16.67%
Jun 30, 20253417.24%928,48646.11%828.06%1427.27%6-25.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.14M2.60%-1.00
Vanguard Total Stock Mkt Idx Inv165.58K1.61%-
Vanguard Institutional Extnd Mkt Idx Tr197.36K0.72%-
Fidelity Extended Market Index139.41K0.51%-8.68K
Abante Quant Value FI63.99K0.23%-
NT R2000 Index Fund - NL316.31K0.17%-58.09K
NT Ext Equity Mkt Idx Fd - L38.24K0.17%-
NT R2000 Value Index Fund - NL279.80K0.15%-55.32K
Northern Trust Extended Eq Market Idx38.24K0.14%-
NT Ext Equity Mkt Index Fund - Lending38.24K0.14%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$1.72M
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$2.00M
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$500.00K
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$430.12K
Apr 03, 2019Mazur Leonard L Executive ChairmanBuy$1.80M

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q1--

CTXR Ownership FAQ


Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 5.20%, followed by 1.80% insiders and 93.00% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 379.61%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Vanguard group (199.26K shares, 1.80%), Geode capital management (246.16K shares, 1.15%), and Blackrock (1.81M shares, 1.14%). Together, they hold 4.08% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Miller financial services is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 14K Citius Pharmaceuticals shares, valued at 12.6K$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.60% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools